BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29050965)

  • 1. The revised staging system for malignant pleural mesothelioma based on surveillance, epidemiology, and end results database.
    Wang S; Ma K; Wang Q; Sun F; Shi Y; Zhan C; Jiang W
    Int J Surg; 2017 Dec; 48():92-98. PubMed ID: 29050965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
    Abdel-Rahman O
    Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.
    Rusch VW; Chansky K; Kindler HL; Nowak AK; Pass HI; Rice DC; Shemanski L; Galateau-Sallé F; McCaughan BC; Nakano T; Ruffini E; van Meerbeeck JP; Yoshimura M;
    J Thorac Oncol; 2016 Dec; 11(12):2112-2119. PubMed ID: 27687962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nomogram to Predict Prognosis in Malignant Pleural Mesothelioma.
    Wang S; Ma K; Chen Z; Yang X; Sun F; Jin Y; Shi Y; Jiang W; Wang Q; Zhan C
    World J Surg; 2018 Jul; 42(7):2134-2142. PubMed ID: 29282508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
    Proto C; Signorelli D; Mallone S; Prelaj A; Lo Russo G; Imbimbo M; Galli G; Ferrara R; Ganzinelli M; Leuzzi G; Greco FG; Calareso G; Botta L; Gatta G; Garassino M; Trama A
    Clin Lung Cancer; 2019 Nov; 20(6):e652-e660. PubMed ID: 31377142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.
    Richards WG; Godleski JJ; Yeap BY; Corson JM; Chirieac LR; Zellos L; Mujoomdar A; Jaklitsch MT; Bueno R; Sugarbaker DJ
    Cancer; 2010 Mar; 116(6):1510-7. PubMed ID: 20108310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial analysis of the international association for the study of lung cancer mesothelioma database.
    Rusch VW; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Pass H; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP;
    J Thorac Oncol; 2012 Nov; 7(11):1631-9. PubMed ID: 23070243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
    Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Nicastri D; Rosenzweig K; Flores RM
    PLoS One; 2015; 10(12):e0145039. PubMed ID: 26660351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.
    Zhuo M; Zheng Q; Chi Y; Jia B; Zhao J; Wu M; An T; Wang Y; Li J; Zhao X; Yang X; Zhong J; Chen H; Dong Z; Wang J; Zhai X; Wang Z
    Thorac Cancer; 2019 May; 10(5):1193-1202. PubMed ID: 30951250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
    Ignatius Ou SH; Zell JA
    J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node involvement and metastatic lymph node ratio influence the survival of malignant pleural mesothelioma: a French multicenter retrospective study.
    Hysi I; Le Pimpec-Barthes F; Alifano M; Venissac N; Mouroux J; Regnard JF; Riquet M; Porte H
    Oncol Rep; 2014 Jan; 31(1):415-21. PubMed ID: 24142233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
    Meyerhoff RR; Yang CF; Speicher PJ; Gulack BC; Hartwig MG; D'Amico TA; Harpole DH; Berry MF
    J Surg Res; 2015 Jun; 196(1):23-32. PubMed ID: 25791825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period.
    Domen A; De Laet C; Vanderbruggen W; Gielis J; Hendriks JM; Lauwers P; Janssens A; Hiddinga B; Van Meerbeeck JP; Van Schil PE
    Acta Chir Belg; 2017 Jun; 117(3):157-163. PubMed ID: 28399779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
    Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
    Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
    Nowak AK; Chansky K; Rice DC; Pass HI; Kindler HL; Shemanski L; Billé A; Rintoul RC; Batirel HF; Thomas CF; Friedberg J; Cedres S; de Perrot M; Rusch VW;
    J Thorac Oncol; 2016 Dec; 11(12):2089-2099. PubMed ID: 27687963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.
    Gill RR; Yeap BY; Bueno R; Richards WG
    J Natl Cancer Inst; 2018 Mar; 110(3):258-264. PubMed ID: 29931180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
    Shang X; Liu J; Li Z; Lin J; Wang H
    BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma.
    Bölükbas S; Eberlein M; Kudelin N; Demes M; Stallmann S; Fisseler-Eckhoff A; Schirren J
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):119-23. PubMed ID: 23242984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.